Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TriSalus TriNav Advance Infusion System

K-Number: K253509 · 2026-09-21

Decision Date2026-09-21
Product CodeKRA
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

TriSalus TriNav Advance Infusion System is the device name listed in this FDA 510(k) record. The listed applicant is Trisalus Life Sciences. It received FDA 510(k) clearance on 2026-09-21 under 510(k) number K253509. The device is classified under product code KRA. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TriSalus TriNav Advance Infusion System?

TriSalus TriNav Advance Infusion System is a medical device that received FDA 510(k) clearance on 2026-09-21. The listed applicant is Trisalus Life Sciences. The 510(k) number is K253509.

When did TriSalus TriNav Advance Infusion System receive FDA 510(k) clearance?

TriSalus TriNav Advance Infusion System received FDA 510(k) clearance on 2026-09-21, under 510(k) number K253509.

Who is the listed applicant for TriSalus TriNav Advance Infusion System?

The FDA 510(k) record lists Trisalus Life Sciences as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TriSalus TriNav Advance Infusion System?

The FDA product code for TriSalus TriNav Advance Infusion System is KRA.

Other records listing Trisalus Life Sciences as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: KRA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑